# Feasibility Study: Heavy Water Tissue Labeling Protocol

> **NCT01708525** · NA · COMPLETED · sponsor: **Ulthera, Inc** · enrollment: 2 (actual)

## Conditions studied

- Skin Laxity

## Interventions

- **DEVICE:** Ulthera® System Treatment
- **OTHER:** Heavy Water

## Key facts

- **NCT ID:** NCT01708525
- **Lead sponsor:** Ulthera, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01708525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01708525, "Feasibility Study: Heavy Water Tissue Labeling Protocol". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01708525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*